Literature DB >> 2656522

Characterization of a suppressor factor that regulates phagocytosis by macrophages in murine cryptococcosis.

R Blackstock1, N K Hall, N C Hernandez.   

Abstract

A T-suppressor factor which inhibits the phagocytic activity of a macrophage subset has been further characterized. This suppressor factor was first described for a murine model of cryptococcosis but was later found to be common to models of immunologic unresponsiveness. The suppressor factor was produced when suppressor cells were cultured in the presence of specific cryptococcal antigen. It could not be extracted from spleen cells and was not induced by antigen in cultures of lymph node cells. The suppressor factor was filtered through Amicon filters of 100-kilodalton (kDa) exclusion limit but was retained by filters excluding molecules of less than 50 kDa. By Sephadex G-100 chromatography, the factor eluted just ahead of bovine serum albumin (68 kDa). The activity of the suppressor factor could not be inhibited by anticryptococcal antibody, but it was inhibited by anti-I-J alloantiserum of the same genotype as the lymphocyte which produced the factor. Absorption with an encapsulated strain of Cryptococcus neoformans removed the suppressor factor from culture supernatants, while absorption with a nonencapsulated mutant or an unrelated yeast cell had not effect. On the basis of these observations, it was apparent that the suppressor factor was idiotypic in nature and that I-J and/or the I-J-interactive molecule played a role in the function of the suppressor factor. The requirement for antigenic stimulation for the production of suppressor factor in vitro distinguished it from the T-suppressor factor 3 described by others which regulates delayed-type hypersensitivity in cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656522      PMCID: PMC313355          DOI: 10.1128/iai.57.6.1773-1779.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

Review 1.  Suppressor cells and immunoregulation.

Authors:  M E Dorf; B Benacerraf
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 2.  An overview of T-suppressor cell circuits.

Authors:  G L Asherson; V Colizzi; M Zembala
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

4.  Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.

Authors:  J W Murphy; J W Moorhead
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

5.  Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells.

Authors:  J W Murphy; R L Mosley; J W Moorhead
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

6.  Modification of macrophage phagocytosis in murine cryptococcosis.

Authors:  M A Morgan; R A Blackstock; G S Bulmer; N K Hall
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

7.  Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity.

Authors:  J W Murphy
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

8.  Equivalence of conventional anti-picryl T suppressor factor in the contact sensitivity system and monoclonal anti-NP TsF3: their final non-specific effect via the T acceptor cell.

Authors:  G L Asherson; M E Dorf; V Colizzi; M Zembala; B M James
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

9.  Suppression of responses to cryptococcal antigen in murine cryptococcosis.

Authors:  B E Robinson; N K Hall; G S Bulmer; R Blackstock
Journal:  Mycopathologia       Date:  1982-12-27       Impact factor: 2.574

10.  THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY.

Authors:  Z A COHN; B BENSON
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

View more
  8 in total

1.  Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.

Authors:  Rebecca Blackstock
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

2.  Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival.

Authors:  R Blackstock; A Casadevall
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

3.  Characterization of the macrophage subset affected and its response to a T suppressor factor (TsFmp) found in cryptococcosis.

Authors:  R Blackstock; N C Hernandez
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

4.  Functional analysis of Histoplasma capsulatum-reactive T-cell hybridomas.

Authors:  G S Deepe; G D Brunner
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Regulation of cytokine expression in mice immunized with cryptococcal polysaccharide, a glucuronoxylomannan (GXM), associated with peritoneal antigen-presenting cells (APC): requirements for GXM, APC activation, and interleukin-12.

Authors:  R Blackstock; N McElwee; E Neller; J Shaddix-White
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.

Authors:  S Mukherjee; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

7.  Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

Review 8.  What makes Cryptococcus neoformans a pathogen?

Authors:  K L Buchanan; J W Murphy
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.